The Journal of BioLaw & Business 
The Intellectual Record of the Times for 21st Century Biotechnology and Life Science Matters
2/6/2006   7:04:22 PM Join Our BioLaw & Business Community Home | Contact Us
BioLaw
BioLaw


You may search the BioLaw & Business Library™ for abstracts and articles of interest by clicking the button below. Our archives contain all current and past issues, reflecting the key topics of the times generic cialis.

Click here to search for articles

This Website is best viewed with Microsoft Internet Explorer 5 and above



The Journal of BioLaw & Business is Proud Media Partner of the Upcoming Events cialis online. online pharmacy viagra.

February 16-17, 2006
Biotech Patents, San Francisco, CA
American Conference Institute
www.americanconference.com
More...

March 13-14, 2006
5th Annual North America Forum for Investing & Partnering in Biotech & Medtech
Sachs Associates
Fairmont Copley Plaza, Boston

www.sachsforum.com
More...

March 26 and 27, 2006
Pharma IQ
Patent Protection and Defense Strategies for Biologics
London, England

www.iqpc.co.uk


May 10-12, 2006
Pharma Discovery
Bethesda North Marriott Hotel & Conference Center
North Bethesda, MD

www.pharmadiscoveryevent.com


May 29-31, 2006
BioMed Israel
The 5th National Life Science & Technology Week
Jerusalem, Israel

www.kenes.com/biomed

Stay on Top of Developments
in Biotechnology and the Life Sciences
The Journal of BioLaw & Business
"The Intellectual Record of the Times"
for 21st Century Biotechnology and Life Science Matters

The Journal of BioLaw & Business (JB&B) is the leading international journal for biotechnology, pharmaceutical and management executives, attorneys, biomedical researchers, entrepreneurs, investors, risk managers, regulatory and policy analysts and other professionals interested in the biotechnology and life sciences sector.

Established in 1997 and in the forefront of a new era, The Journal of BioLaw & Business provides practical guidance, expert insights and substantive analysis of 21st century biotechnology and life science matters from an interdisciplinary perspective - reflective of the sector's nature.

Published quarterly, with topic-specific thematic supplements and electronic updates, JB&B offers timely reporting, thoughtful analysis, case studies and practical solutions to current and future concerns in these emerging fields viagra. It is designed for those who want to stay ahead of the knowledge curve about rapidly changing innovations viagra. Our distinguished advisors and authors offer "real world" perspectives and the practical tools necessary to meet todays' toughest challenges and to develop the Best BioLaw & Business Practices™.

It's the first professional and substantive interdisciplinary publication of its kind to help you:

  • Keep track of emerging scientific, legal, business, regulatory and policy developments
  • Gain a better understanding of client and consumer information needs and business opportunities
  • Communicate more effectively about topics of growing global importance
  • Shape Best BioLaw & Business Practices™ and responsible life sciences policy
  • Benefit from the perspectives and practical guidance of international experts and thought leaders
        Click here to learn more about JB&B

Subscriber Benefits

JB&B subscribers stay on the cutting-edge and have practical, up-to-date information on the latest trends and thinking in the field . In addition to the quarterly print journal, subscribers receive:

  On-line access to current full text articles in PDF format
  Electronic updates
  Advance notification of selected meetings, events and invitational forums
  Subscriber discounts on BioLaw & Business Supplements, special   publications and events
  Basic Membership in the BioLaw & Business Society™

For All Visitors

The Journal of BioLaw & Business posts abstracts of all articles and columns published since 1997. To read a specific editorial, article or column, simply place it in your "JB&B Briefcase," provide your credit card information in our secure zone and download the content directly from the website.

To purchase a subscription to The Journal of BioLaw & Business, which includes on-line full text access to the current volume, click here. We invite you to join our BioLaw & Business community!


The JB&B Briefcase  

When you find the topic and papers you are interested in reading, click on "Add to JB&B Briefcase." You can add and remove articles from your JB&B briefcase at any time before you check out. A single full-text paper or multiple papers can be purchased on-line by using your credit card. All transactions are secure.

Click here to view the abstracts



  
Editorial Correspondence : editor@biolawbusiness.com
Subscription Information : subscriptions@biolawbusiness.com
Disclaimer | Privacy Statement | User Agreement
Copyright © 2003 by The Journal of BioLaw & Business.All Rights Reserved.
A Publication of Applied Biogenuity™  Design by Applied Biogenuity Ink™
All visitors must agree to and follow website Rules, Terms and Conditions
Quick Links:
Current Subscriber Login
 Username:
 Password:
Forgot Password? Click Here
Not a Member? Join Now!
Current Print Subscriber? Click here to register

Obtain a FREE COPY of the Journal of Biolaw & Business.Simply complete the Survey and each month we will send the first 100 respondents a copy of a recently published issue. Click Here

Biopharmaceutical Outsourcing, Contracting
and Partnering Conference

March 7-8, 2005 San Diego, CA
more...

Sachs Associates Investor Conferences in Association with Bloomberg LP Inaugural CRO Partnering Forum
15 March 2005, Boston
more...

4th Annual North America Forum for Investing and Partnering in Biotech and Medtech
16 - 17 March 2005, Boston
more...

Biotech Israel 2005
THE ISRAEL BIOMEDICAL
 TECHNOLOGIES

MAY 24-26, 2005 TEL AVIV, ISRAEL

CONFERENCE & EXHIBITION
more...

5th Annual Biotech in
Europe Investor Forum

4 - 5 October 2005, Zurich
more...

"A thoughtful publication bringing together unique insights into strategy, business and law in biotech and pharma."

- Stelios Papdopoulos, PhD
Managing Director, Investment Banking
SG Cowen Securities Corporation


"BioLaw is a must read for anyone concerned about biotech and life science issues. It covers research to royalties and everything in between. The articles and regular columns feature a unique blend of academic and practical insights from all of the relevant disciplines.I strongly recommend it."

- Professor Mark Rothstein, JD, Director
Institute for Bioethics, Health Policy and Law
University of Louisville School of Medicine